期刊文献+

异福片制粒工艺改进 被引量:1

Improvement of Granulation Technology of Rifampin and Isoniazid Tablets
原文传递
导出
摘要 目的:对异福片制粒工艺进行改进,以解决制粒中粉尘污染严重的问题。方法:选用聚乙二醇(PEG)、共聚维酮为黏合剂,采用熔融制粒工艺制备片剂;以脆碎度、溶出度等为考察指标筛选处方;采用高效液相色谱法对制剂中利福平、醌式利福平、N-氧化利福平、利福霉素SV和异烟腙5种物质的含量进行测定,选择3批新方法和2批原干法制粒工艺产品进行影响因素试验和稳定性试验,比较其中的5种物质的含量变化。结果:优选处方以PEG600080mg、共聚维酮10mg为黏合剂,交联聚乙烯吡咯烷酮(PVPP)20mg为崩解剂,70℃沸腾干燥。所制制剂脆碎度0.39%,溶出度利福平78.55%、异烟肼87.92%。利福平检测质量浓度在0.2~20mg/L内,醌式利福平、利福霉素SV、N-氧化利福平和异烟腙检测质量浓度在0.2~10mg/L内均与其峰面积呈良好的线性关系,回收率为99.5%~100.4%,RSD为0.98%~2.11%(n=9)。与原干法产品比较,新工艺在考察条件内5种物质的含量增长情况均基本一致。结论:采用熔融制粒工艺能有效减少粉尘污染,所制产品与原工艺产品质量相当。 OBJECTIVE:To improve granulation technology of Rifampin and isoniazid tablets,and to solve the problem of dust pollution in granulation.METHODS:The tablets were prepared by melting granulation method using polyethylene glycol(PEG)and copolyvidone as adhesive;the formulation was screened using friability and dissolution rate as index.The contents of rifampicin,rifampicin quinone,N-oxide rifampicin,rifamycin SV and isoniazone were determined by HPLC.Influential factor test and stability test were conducted with 3 batches by new methods and 2 batches by original dry granulation.The contents of 5 kinds of substance were compared.RESULTS:The optimal formulation was as follows:PEG6000 80 mg and copolyvidone 10 mg as adhesive,crospolyvinylpyrrolidone(PVPP)20 mg as disintegrants,fluidizing drying at 70 ℃.The friability of prepared tablets was 0.39%,and the dissolution rate of rifampin was 78.55% and that of isoniazid was 87.92%.The linear range of rifampin was 0.2-20 mg/L,and linear ranges of rifampicin quinone,rifamycin SV,N-oxide rifampicin and isoniazone were 0.2-10 mg/L.Their recoveries were 99.5%-100.4% with RSD of 0.98%-2.11%(n=9).Compared with original dry granulation,the growth of 5 kinds of substances were similar basically by new technology.CONCLUSIONS:The melting granulation technology can reduce dust pollution efficiently;the quality of prepared tablets using two methods has no obvious changes.
出处 《中国药房》 CAS CSCD 2013年第29期2746-2749,共4页 China Pharmacy
关键词 异福片 干法制粒 熔融制粒 高效液相色谱法 粉尘污染 Rifampin and isoniazid tablets Dry granulation Melting granulation HPLC Dust pollution
  • 相关文献

参考文献2

二级参考文献6

共引文献14

同被引文献33

  • 1Moroni A. A novel copovidone binder for dry granulation anddirect compression tabletting [J]. Pharm Tech, 2001, 24(9):8-12.
  • 2Kolter K, Flick D. Structure and dry binding activity ofdifferent polymers, including Kollidon VA 64 [J]. Drug DevInd Pharm, 2000, 26(11): 1159-1165.
  • 3Maniruzzaman M, Rana MM, Boateng JS, et al. Dissolutionenhancement of poorly water-soluble APIs processed by hot-melt extrusion using hydrophilic polymers [J]. Drug Dev IndPharm, 2013, 39(2): 218-227.
  • 4Mahmah 0, Tabbakh R, Kelly A,et al. A comparative studyof the effect of spray drying and hot-melt extrusion onthe properties of amorphous solid dispersions containingfelodipine [J]. J Pharm Pharmacol’ 2014, 66 (2): 275-284.
  • 5Leuner C, Dressman J. Improving drug solubility for oraldelivery using solid dispersions [J]. Eur J Pharm Biopharm,2000,50(1):47-60.
  • 6Vasconcelos T,Sarmento B, Costa P. Solid dispersions asstrategy to improve oral bioavailability of poor water solubledrugs [J]. Drug Discov Today, 2007,12 (23-24): 1068-1075.
  • 7Matsumoto T, Zografi G. Physical properties ofsolid molecular dispersions of indomethacin withpoly (vinylpyrrolidone) and poly (vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization [J].Pharm Res, 1999,16(11): 1722-1728.
  • 8Rowe RC,Sheskey PJ, Quinn ME. Handbook ofpharmaceutical excipients [M] . 6th ed, London:Pharmaceutical Press and American Pharmacists Association,2009: 197.
  • 9He H, Yang R, Tang X. In vitro and in vivo evaluation offenoflbrate solid dispersion prepared by hot-melt extrusion[J]. Drug Dev Ind Pharm, 2010,36(6): 681-687.
  • 10Ghebremeskel AN, Vemavarapu C, Lodaya M. Use ofsurfactants as plasticizers in preparing solid dispersionsof poorly soluble API: stability testing of selected soliddispersions [J]. Pharm Res, 2006,23 (8): 1928-1936.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部